ストックスクリーナーアプリを入手
3.16
2.60%
0.08
アフターアワーズ：
3.16
前日終値:
$3.08
開ける：
$3.12
24時間の取引高:
11,433
Relative Volume:
0.21
時価総額：
$5.61M
収益：
$770.00K
当期純損益:
$-38.84M
株価収益率:
-0.2225
EPS:
-14.2049
ネットキャッシュフロー:
$-43.02M
1週間 パフォーマンス:
-11.98%
1か月 パフォーマンス:
-21.20%
6か月 パフォーマンス:
-66.06%
1年 パフォーマンス:
-70.74%
1日の値動き範囲:
$3.00
$3.2134
1週間の範囲:
$2.991
$3.59
52週間の値動き範囲:
$2.84
$37.50
Lyra Therapeutics Inc Stock (LYRA) Company Profile
LYRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LYRA
Lyra Therapeutics Inc
|
3.16 | 5.47M | 770.00K | -38.84M | -43.02M | -14.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.13 | 115.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.31 | 81.12B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
400.17 | 52.54B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.99 | 51.78B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.12 | 37.12B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-07 | ダウングレード | BofA Securities | Buy → Underperform |
| 2024-05-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2024-05-07 | ダウングレード | Jefferies | Buy → Hold |
| 2024-05-06 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-10-06 | 再開されました | BTIG Research | Buy |
| 2023-08-31 | 開始されました | H.C. Wainwright | Buy |
| 2022-05-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-05-26 | 開始されました | BTIG Research | Buy |
| 2020-05-26 | 開始されました | BofA/Merrill | Buy |
| 2020-05-26 | 開始されました | Jefferies | Buy |
| 2020-05-26 | 開始されました | William Blair | Outperform |
すべてを表示
Lyra Therapeutics Inc (LYRA) 最新ニュース
Lyra Therapeutics (NASDAQ:LYRA) Trading Up 0.3% – Time to Buy? - Defense World
LYRA (Lyra Therapeutics) EV-to-OCF : -0.46 (As of Dec. 22, 2025) - GuruFocus
Can Lyra Therapeutics Inc. stock surprise with earnings upside2025 Historical Comparison & Free AI Powered Buy and Sell Recommendations - Bölüm Sonu Canavarı
Is Lyra Therapeutics Inc. stock a buy for dividend growthJuly 2025 Movers & Low Risk High Win Rate Stock Picks - Улправда
Lyra Therapeutics Earnings Notes - Trefis
Can Lyra Therapeutics Inc. stock sustain revenue growthJuly 2025 Reactions & Precise Buy Zone Tips - Улправда
Take Profit: Will Lyra Therapeutics Inc. stock outperform value stocksPortfolio Performance Report & Expert Curated Trade Setup Alerts - Улправда
Will Lyra Therapeutics Inc. stock outperform value stocksGap Down & Low Drawdown Trading Strategies - ulpravda.ru
Why Lyra Therapeutics Inc. stock remains on buy listsJuly 2025 WrapUp & Weekly High Momentum Picks - Улправда
Insmed drops as it abandons brensocatib in rhinosinusitis - Seeking Alpha
Lyra Therapeutics Stock Rockets 56% With 6-Day Winning Streak - Trefis
Will Lyra Therapeutics Inc. stock pay special dividends2025 Trade Ideas & High Conviction Investment Ideas - Newser
Lyra Therapeutics (LYRA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Why Lyra Therapeutics Inc. stock is popular among millennials2025 Investor Takeaways & Expert Approved Momentum Ideas - Newser
Will Lyra Therapeutics Inc. stock benefit from infrastructure spendingQuarterly Earnings Summary & Stepwise Entry/Exit Trade Alerts - Newser
Published on: 2025-11-27 15:46:05 - moha.gov.vn
PERCEPTIVE ADVISORS LLC Reduces Stake in Lyra Therapeutics Inc - GuruFocus
Will Product Innovation Drive Hisar Spinning Mills Limited Stock in YEARRisk Management Strategies & Free Extraordinary Earning Power - earlytimes.in
Will Lyra Therapeutics Inc. stock deliver shareholder valueMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Can Lyra Therapeutics Inc. stock deliver sustainable ROEBull Run & Consistent Return Strategy Ideas - newser.com
What technical charts say about Lyra Therapeutics Inc. stockVolume Spike & Weekly Watchlist for Hot Stocks - newser.com
How to interpret RSI for Lyra Therapeutics Inc. stock2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Will Lyra Therapeutics Inc. outperform the marketEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
How to escape a deep drawdown in Lyra Therapeutics Inc.July 2025 Recap & Weekly Market Pulse Alerts - newser.com
Is Lyra Therapeutics Inc. stock in correction or buying zoneJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Is Lyra Therapeutics Inc. stock overvalued by current metricsExit Point & Intraday High Probability Setup Alerts - newser.com
What machine learning models say about Lyra Therapeutics Inc.Trade Volume Report & AI Driven Stock Reports - newser.com
What valuation multiples suggest for Lyra Therapeutics Inc. stockJuly 2025 Levels & Weekly Return Optimization Alerts - newser.com
Risk adjusted return profile for Lyra Therapeutics Inc. analyzedMarket Weekly Review & Growth Focused Investment Plans - newser.com
Can a trend reversal in Lyra Therapeutics Inc. lead to recoveryWeekly Trade Report & Weekly Breakout Stock Alerts - newser.com
Lyra Therapeutics Faces Critical Juncture as Challenges Mount - Ad-hoc-news.de
What indicators show strength in Lyra Therapeutics Inc.2025 Market Sentiment & Free Safe Entry Trade Signal Reports - newser.com
Lyra Therapeutics Inc (LYRA) 財務データ
収益
当期純利益
現金流量
EPS
Lyra Therapeutics Inc (LYRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 12 '25 |
Sale |
4.06 |
8,745 |
35,499 |
17,239 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 11 '25 |
Sale |
4.31 |
5,320 |
22,954 |
18,122 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 06 '25 |
Sale |
5.18 |
32,149 |
166,529 |
22,521 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 07 '25 |
Sale |
4.75 |
19,739 |
93,695 |
20,528 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Nov 10 '25 |
Sale |
4.54 |
18,502 |
83,995 |
18,659 |
0.57%
大文字化:
|
ボリューム (24 時間):